{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:41:26Z","timestamp":1791376886113,"version":"4.3.2"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007162","name":"Guangdong Science and Technology Department","doi-asserted-by":"publisher","award":["2018A030313525"],"award-info":[{"award-number":["2018A030313525"]}],"id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402963"],"award-info":[{"award-number":["81402963"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81962163"],"award-info":[{"award-number":["81962163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Disease","doi-asserted-by":"publisher","award":["SKLRDQN201702"],"award-info":[{"award-number":["SKLRDQN201702"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Cellular Molecular Medi"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioma is a common brain malignancy for which new drug development is urgently needed because of radiotherapy and drug resistance. Recent studies have demonstrated that artemisinin (ARS) compounds can display antiglioma activity, but the mechanisms are poorly understood. Using cell lines and mouse models, we investigated the effects of the most soluble ARS analogue artesunate (ART) on glioma cell growth, migration, distant seeding and senescence and elucidated the underlying mechanisms. Artemisinin effectively inhibited glioma cell growth, migration and distant seeding. Further investigation of the mechanisms showed that ART can influence glioma cell metabolism by affecting the nuclear localization of SREBP2 (sterol regulatory element\u2010binding protein 2) and the expression of its target gene HMGCR (3\u2010hydroxy\u20103\u2010methylglutaryl coenzyme A reductase), the rate\u2010limiting enzyme of the mevalonate (MVA) pathway. Moreover, ART affected the interaction between SREBP2 and P53 and restored the expression of P21 in cells expressing wild\u2010type P53, thus playing a key role in cell senescence induction. In conclusion, our study demonstrated the new therapeutic potential of ART in glioma cells and showed the novel anticancer mechanisms of ARS compounds of regulating MVA metabolism and cell senescence.<\/jats:p>","DOI":"10.1111\/jcmm.14717","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T08:04:58Z","timestamp":1574237098000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence"],"prefix":"10.1111","volume":"24","author":[{"given":"Shupei","family":"Wei","sequence":"first","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[{"name":"People's Hospital of Rizhao Rizhao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Research Lab Center Guizhou Provincial People's Hospital Guiyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Yin","sequence":"additional","affiliation":[{"name":"People's Hospital of Rizhao Rizhao China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Liu","sequence":"additional","affiliation":[{"name":"Xiangya Hospital Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Xiangya Hospital Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Zeng","sequence":"additional","affiliation":[{"name":"Xiangya Hospital Central South University Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Nie","sequence":"additional","affiliation":[{"name":"Clinical Research Lab Center Guizhou Provincial People's Hospital Guiyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8433-2509","authenticated-orcid":false,"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University Guangzhou China"},{"name":"Clinical Research Lab Center Guizhou Provincial People's Hospital Guiyang China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"147","article-title":"[(7)Treatment strategy for grade 2 glioma:surgery, radiotherapy, and chemotherapy]","volume":"47","author":"Nitta M","year":"2019","journal-title":"No Shinkei Geka Neurological Surgery"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"e_1_2_9_4_1","article-title":"Artemisinin: a promising adjunct for cancer therapy","volume":"10","author":"Waseem Y","year":"2018","journal-title":"Cureus"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.01.041"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0122-6"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042703"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2008.00360.x"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0197"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2017.42"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.11.026"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e328336f57b"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy125"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgv098"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0534"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4847"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.01.013"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)34313-3"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.03.008"},{"key":"e_1_2_9_20_1","first-page":"317","article-title":"Requirement for mevalonate in the control of proliferation of human breast cancer cells","volume":"12","author":"Wejde J","year":"1992","journal-title":"Anticancer Res"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910258107"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4817"},{"key":"e_1_2_9_23_1","first-page":"331","article-title":"Human hydroxymethylglutaryl\u2010coenzyme A reductase (HMGCR) and statin sensitivity","volume":"47","author":"Jawaid S","year":"2010","journal-title":"Indian J Biochem Biophys"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep07593"},{"key":"e_1_2_9_25_1","first-page":"355","article-title":"Long\u2010term statin therapy improves oncological outcome after radical gastrectomy for stage II and III gastric cancer","volume":"34","author":"Nam DH","year":"2014","journal-title":"Anticancer Res"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3003"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14495-6"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0114"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0128-0"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-019-0110-x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3711"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3773"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1044"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2018.04.003"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020350"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8920"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201900146R"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170399"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.12.017"}],"container-title":["Journal of Cellular and Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.14717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcmm.14717","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcmm.14717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T09:01:15Z","timestamp":1693213275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcmm.14717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1111\/jcmm.14717"],"URL":"https:\/\/doi.org\/10.1111\/jcmm.14717","archive":["Portico"],"relation":{},"ISSN":["1582-1838","1582-4934"],"issn-type":[{"value":"1582-1838","type":"print"},{"value":"1582-4934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"2019-06-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}